Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Dall'Era

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
World Journal of Urology|February 16, 2021
Liquid biomarkers in active surveillanceMarc Dall'Era
The Journal of Urology|March 2, 2019
Editorial CommentMarc Dall'Era
The Journal of Urology|May 17, 2017
Editorial CommentMarc Dall'Era
The Journal of Urology|April 30, 2013
Editorial commentMarc Dall'Era
The Journal of Urology|June 17, 2015
What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer?Marc Dall'Era, Peter Carroll
Nature Clinical Practice. Urology|July 27, 2007
The optimal management of clinically localized prostate cancer: the debate continuesMarc Dall'Era, Badrinath Konety
European Urology Focus|August 28, 2022
Discordant Endorsement of Prostate Cancer Biomarkers Across Major GuidelinesManolis Pratsinis, Marc Dall'Era
The Journal of Urology|October 18, 2016
Genomic and Biological Markers to Select Treatment for Patients with Prostate Cancer: Choose Wisely, My FriendMarc Dall'Era, Christopher Evans
The Urologic Clinics of North America|September 30, 2024
Preventing Infections After Prostate Biopsy: Prophylactic Antibiotics, Prebiopsy Rectal Culture, and Biopsy ApproachNicolai Hubner, Marc Dall'Era
The Journal of Urology|April 18, 2007
Prostate cancer--more information and more questionsMarc Dall'Era, Peter R Carroll
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
World Journal of Urology|February 16, 2021
Liquid biomarkers in active surveillanceMarc Dall'Era
The Journal of Urology|March 2, 2019
Editorial CommentMarc Dall'Era
The Journal of Urology|May 17, 2017
Editorial CommentMarc Dall'Era
The Journal of Urology|April 30, 2013
Editorial commentMarc Dall'Era
The Journal of Urology|June 17, 2015
What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer?Marc Dall'Era, Peter Carroll
Nature Clinical Practice. Urology|July 27, 2007
The optimal management of clinically localized prostate cancer: the debate continuesMarc Dall'Era, Badrinath Konety
European Urology Focus|August 28, 2022
Discordant Endorsement of Prostate Cancer Biomarkers Across Major GuidelinesManolis Pratsinis, Marc Dall'Era
The Journal of Urology|October 18, 2016
Genomic and Biological Markers to Select Treatment for Patients with Prostate Cancer: Choose Wisely, My FriendMarc Dall'Era, Christopher Evans
The Urologic Clinics of North America|September 30, 2024
Preventing Infections After Prostate Biopsy: Prophylactic Antibiotics, Prebiopsy Rectal Culture, and Biopsy ApproachNicolai Hubner, Marc Dall'Era
The Journal of Urology|April 18, 2007
Prostate cancer--more information and more questionsMarc Dall'Era, Peter R Carroll
Pageof 5